Decompression of enlarged mediastinal lymph nodes due to mycobacterium tuberculosis causing severe airway obstruction

Pierre Goussard1, Robert P Gie1, Jacques T Janson2

  • 1Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Children's Hospital, Cape Town.

Insights

Tuberculosis lymph node decompression is a safe and effective procedure for children with severe airway obstruction. This intervention offers low rates of complications, failure, and death.

Area of Science:

  • Pediatric Pulmonology
  • Thoracic Surgery
  • Infectious Diseases

Background:

  • Enlarged tuberculosis (TB) lymph nodes can cause life-threatening airway obstruction in children.
  • Indications, safety, and efficacy of TB lymph node decompression are not well-documented.
  • This study addresses the need for data on TB lymph node decompression in pediatric airway compression.

Purpose of the Study:

  • To describe indications for TB lymph node decompression in children with severe airway compression.
  • To evaluate the efficacy of TB lymph node decompression.
  • To identify factors influencing outcomes of the procedure.

Main Methods:

  • Prospective cohort study of children (3 months–13 years) with airway obstruction from TB lymph nodes.
  • Airway obstruction assessed via bronchoscopy and chest CT scans.
  • Transthoracic lymph node decompression performed when indicated.

Main Results:

  • 34% of 250 children required lymph node decompression, often after failed medical treatment.
  • Compression of the bronchus intermedius and left main bronchus predicted need for decompression.
  • Decompression had low complication (8%), failure (2%), and zero fatality rates.

Conclusions:

  • Approximately one-third of pediatric TB cases with severe airway obstruction necessitate lymph node decompression.
  • Transthoracic decompression is a safe procedure with minimal adverse events.
  • The study confirms the safety and efficacy of this intervention for pediatric airway obstruction due to TB lymph nodes.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.5K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
752